• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

tirzepatide

Eli Lilly
Pharma

Lilly touts Zepbound-Taltz combo in patients with obesity, PsA

Taking Zepbound with Taltz could help patients with both obesity and psoriatic arthritis more than Taltz on its own, according to new Eli Lilly data.
Fraiser Kansteiner Jan 8, 2026 2:00pm
White House

Lilly, Novo reach GLP-1 pricing deals with White House

Nov 6, 2025 12:26pm
pause button on blue background

Lilly pauses UK orders on its diabetes and obesity med Mounjaro

Aug 28, 2025 11:08am
Mounjaro tirzepatide

Mounjaro measures up to Trulicity in Eli Lilly cardio trial

Jul 31, 2025 8:12am
compounding compounding pharmacy drug preparation formulation

Experts hold line against mass compounding of GLP-1 obesity meds

Jun 27, 2025 10:36am
law and order concept

Compounders ordered to halt production of semaglutide knockoffs

Apr 25, 2025 10:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings